Three of the most commonly diagnosed conditions in women worldwide are also among the least discussed, least accurately diagnosed and least adequately treated. A sweeping new review published in the journal Women’s Health has pulled together research on bacterial vaginosis, yeast infections and urinary tract infections and what it found goes far beyond the physical discomfort most people associate with these conditions.

When these infections recur, as they frequently do, the consequences ripple into nearly every area of a woman’s life: her mental health, her relationships, her ability to work and her financial stability. The review makes a compelling case that the medical community has significantly underestimated how seriously these conditions affect the women who live with them.

The scale of the problem

The numbers establish just how widespread these conditions are. Nearly 1 in 3 women will experience a UTI before age 24. Approximately 75% of women will deal with at least one yeast infection during their lifetime. Bacterial vaginosis remains the most common vaginal condition among reproductive-age women globally, affecting roughly 30% of women each year.

Recurrence is where the real damage accumulates. Single episodes are difficult enough. But for the substantial portion of women who experience these infections repeatedly, the physical symptoms are only the beginning of what they are managing.

A mental health crisis hiding in plain sight

The review’s findings on psychological impact are striking. Women suffering from recurrent yeast infections and UTIs consistently scored lower across every measure of quality of life compared to the general population. The mental health burden of recurring yeast infections was found to be comparable to living with type 2 diabetes. The overall quality of life disruption matched conditions like asthma or chronic obstructive pulmonary disease conditions that receive considerably more public and medical attention.

The connection to diagnosed mental health conditions is equally alarming. According to the review, 42% of women diagnosed with recurrent yeast infections also had depression or anxiety. Women with recurring UTIs showed significantly lower mental health scores across the board, with the sudden, painful onset of episodes closely linked to heightened anxiety between flare ups. Women dealing with recurrent bacterial vaginosis described feelings of helplessness and loss of control that intensified with each return of symptoms.

One data point stands out particularly: women with yeast infections were found to be twice as likely to receive antidepressant prescriptions compared to women visiting doctors for contraception. That figure suggests the emotional burden of these conditions runs considerably deeper than most clinical encounters acknowledge.

How these infections damage relationships and intimacy

The review also documents the significant toll these conditions take on romantic and sexual relationships. Nearly 79% of women with recurrent yeast infections reported that their condition affected their sexual activity, while 57% said it had strained their relationships. Women with bacterial vaginosis described deep self consciousness about vaginal odor, leading many to avoid intimacy entirely or restrict certain sexual practices. Some reported that partners responded poorly when the subject was raised, reinforcing harmful and inaccurate assumptions that the condition was linked to poor hygiene or infidelity.

For women dealing with UTIs, a large-scale analysis of more than 80,000 social media posts found that abstaining from sex was a common prevention strategy. Women with recurrent infections were significantly less sexually active than those who had experienced only a single episode a pattern that compounds the social and emotional isolation many already feel.

The $13 billion financial burden

The combined economic cost of these three conditions is estimated at more than $13 billion per year in the United States alone. UTIs account for roughly $3.5 billion annually when factoring in both medical costs and missed work. Bacterial vaginosis carries an estimated $4.8 billion annual price tag a figure that nearly triples when its associations with preterm birth and increased HIV susceptibility are factored in. Yeast infections add another $2.84 billion.

Lost productivity represents a significant but frequently overlooked component of that total. Women with recurrent yeast infections miss an average of six hours of work per episode. Those with bacterial vaginosis reported avoiding work due to embarrassment about odor and described reluctance to work in close proximity to others or use shared restrooms. Women whose UTI treatments failed missed even more work hours, compounding the financial strain of what often becomes a cycle of repeated doctor visits, diagnostic tests and prescriptions.

Women are not being believed or correctly diagnosed

Across the research gathered in this review, frustration with the medical system emerged as a consistent and painful theme. Women reported being told their infections would resolve on their own, being dismissed when they described the impact on their daily lives, and cycling through repeated courses of antibiotics that offered only temporary relief before symptoms returned.

Diagnostic accuracy is a serious and underappreciated part of the problem. One study found that 77% of clinical yeast infection diagnoses were incorrect. Another showed that 61% of physician diagnosed bacterial vaginosis cases were wrong. For UTIs, standard urine cultures miss approximately 50% of non E. coli pathogens meaning a significant proportion of women presenting with real symptoms are told their results are normal and nothing is wrong.

What better care could actually change

The review’s authors drew a clear line between adequate treatment and improved mental health outcomes. When women with recurrent UTIs received prophylactic treatment, their rates of depression and anxiety decreased and their overall quality of life improved. The implication is not subtle: the suffering many women are experiencing is not inevitable. It is, in significant part, a consequence of inadequate diagnostics, limited treatment options and a medical culture that has repeatedly failed to treat these conditions with the seriousness they deserve.

For millions of women who have spent years managing these conditions largely on their own cycling through home remedies and lifestyle adjustments after medicine offered them little that conclusion will likely feel both validating and overdue